Is Amera profitable in 2026?

Amera has not disclosed profitability. GeekWire independently confirmed on 2025-12-29 that Amera is generating revenue from multiple plan administrators, but no profit, margin, or ARR figures have been made public as of July 2026.

Could AI replace Amera's core product?

Amera's core pitch, turning unstructured claim PDFs into structured data, is exactly what frontier document AI models like GPT-4o, Claude, and Gemini vision already do well, which is why analysts flag the extraction layer as commoditizing within 18 to 24 months.

Who owns Amera and who founded it?

Amera is privately held, founded in 2025 by CEO Deep Kapur (ex-Microsoft, ex-Protocol Labs) and co-founder Louise Tanski (ex-QueryStax, acquired by Moonshot Brands). Both previously worked at Rupa Health. It joined Y Combinator's Fall 2025 batch.

Who is Amera's biggest competitor?

Amera competes with claims-automation peers like Rialtic, Qantev (which raised $31.2M in October 2024), CoverSelf, and YC peers LunaBill and Cair Health, plus incumbent core-admin platforms and self-administering carriers like UnitedHealth and Cigna that could bolt on similar features.

How much funding has Amera raised?

Amera has disclosed $500K in seed funding from Y Combinator as of September 29, 2025. No subsequent priced round or valuation has been publicly reported as of July 2026.

What is the Amera and IPS partnership?

On July 23, 2026, Amera announced a partnership with Integrated Payor Solutions (IPS) to power stop-loss reporting embedded directly into IPS's platform for its TPA customer base, currently in phased rollout across that customer base.

YC Fall 2025 · United States

Amera

Amera automates claims normalization and processing for health insurance payers and TPAs.

Losing its protection

Assessed 27 July 2026 · Evidence as of 27 July 2026

The structural protection is eroding.

On the recordSince 27 July 2026 · Checkable from H1 2027 · Every call on the record Checkpoint: IPS partnership rollout conversion to durable revenue and a possible second platform embed

The call

Amera has a real foothold in messy claims normalization but is racing to lock in workflows before frontier models or platform incumbents absorb the task.

Amera helps insurance companies and self-funded employers sort through messy claim documents and turn them into clean data. Right now the hardest part is reading and understanding those documents, but newer AI tools like ChatGPT and Claude are getting very good at that for free or cheap, which means Amera's main skill could become easy to copy. Big insurance companies like UnitedHealth, Optum, and HealthEdge are not moving fast today, but they have the money and power to build this themselves once they decide to. The one thing that could save Amera is if they lock customers into their software by making it work so smoothly with insurance workflows and specific business rules that switching becomes expensive and painful, not just building a better way to read documents.

Why

AI pressure: Frontier vision models like GPT-4o, Claude, Gemini doing document extraction. Claim-PDF parsing and normalization is the exact task frontier models are absorbing as a built-in feature. Could AI do the core job? Yes, likely.

Bigger players: HealthEdge, Optum/Change Healthcare, self-administering carriers like UnitedHealth and Cigna. These vendors already own the claims platform and could bolt on their own pre-processing layer without Amera. Could a giant copy it? Yes, easily.

What protects it. Getting embedded inside a TPA platform like IPS with payer-specific rules built in, so switching means rebuilding workflows, not just swapping a parser.

What would change this call

IPS partnership converts from phased rollout to durable embedded revenue within 6-12 months. Shows whether Amera's workflow lock-in is real or just a pilot.
Amera announces a second platform embed beyond IPS. Tests if the distribution strategy is repeatable, not a one-off deal.
HealthEdge or Optum ships a competing claim pre-processing feature. Shows incumbents closing the gap on Amera's core offering.

Key numbers

Covers roughly 100,000 members through current customers (n.d.)
Team of 8 people (2026-07-21)
IPS partnership for stop-loss reporting announced (2026-07-23)

Named risks

Core claim-extraction layer commoditizing via frontier document AI models (GPT-4o, Claude, Gemini vision). Severity: high
Only one named commercial embed (IPS) confirmed; no structural lock-in demonstrated yet. Severity: high
Crowded wedge with multiple funded YC peers and better-capitalized rivals like Qantev chasing same niche. Severity: medium
Small 8-person team and unresolved HQ location (Seattle vs New York) raise execution uncertainty. Severity: medium

Rivals, as read in July 2026

Rival	Direction	Evidence
Optum/Change Healthcare	gaining on	Sits upstream of claims workflow as incumbent; still stabilizing post 2024 ransomware attack as of 2025-04-15
HealthEdge	gaining on	Core-admin platform could bolt on ingestion/normalization without business-model conflict, only slower to move
Qantev	gaining on	Raised $31.2M in October 2024 for AI-driven claims management, better capitalized than Amera
Rialtic	contesting	Atlanta-based payment-processing SaaS for payers, founded 2020, direct wedge competitor
LunaBill	contesting	YC-backed peer with ~$764K contracted ARR reported as of 2026-07-21
Cair Health	contesting	YC-backed peer claiming 100+ practices served, per YC directory 2026-07-21

Questions people ask

Is Amera profitable in 2026?: Amera has not disclosed profitability. GeekWire independently confirmed on 2025-12-29 that Amera is generating revenue from multiple plan administrators, but no profit, margin, or ARR figures have been made public as of July 2026.
Could AI replace Amera's core product?: Amera's core pitch, turning unstructured claim PDFs into structured data, is exactly what frontier document AI models like GPT-4o, Claude, and Gemini vision already do well, which is why analysts flag the extraction layer as commoditizing within 18 to 24 months.
Who owns Amera and who founded it?: Amera is privately held, founded in 2025 by CEO Deep Kapur (ex-Microsoft, ex-Protocol Labs) and co-founder Louise Tanski (ex-QueryStax, acquired by Moonshot Brands). Both previously worked at Rupa Health. It joined Y Combinator's Fall 2025 batch.
Who is Amera's biggest competitor?: Amera competes with claims-automation peers like Rialtic, Qantev (which raised $31.2M in October 2024), CoverSelf, and YC peers LunaBill and Cair Health, plus incumbent core-admin platforms and self-administering carriers like UnitedHealth and Cigna that could bolt on similar features.
How much funding has Amera raised?: Amera has disclosed $500K in seed funding from Y Combinator as of September 29, 2025. No subsequent priced round or valuation has been publicly reported as of July 2026.
What is the Amera and IPS partnership?: On July 23, 2026, Amera announced a partnership with Integrated Payor Solutions (IPS) to power stop-loss reporting embedded directly into IPS's platform for its TPA customer base, currently in phased rollout across that customer base.

Timeline

2026-07-23Amera announces partnership with Integrated Payor Solutions for embedded stop-loss reporting
2025-12-29GeekWire independently confirms Amera is generating revenue from multiple plan administrators
2025-11-06Amera publicly launches via Y Combinator Launch YC post
2025-09-29Amera receives $500K seed funding from Y Combinator
2025Amera founded by Deep Kapur and Louise Tanski
2024-10Competitor Qantev raises $31.2M for AI-driven claims management

Revision history

27 July 2026

First assessed. Losing its protection. The text above is fixed as of this date and is not edited afterwards.

In the same band

Nexus Terrain Metorial